A dilemma born of progress: switching from clozapine to a newer antipsychotic.
Rafal
S
S
Department of Psychiatry, Massachusetts Mental Health Center, Harvard Medical School, Boston 02115, USA.
Tsuang
M T
MT
Carpenter
W T
WT
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001294:Attitude to Health; D001569:Benzodiazepines; D003024:Clozapine / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000523:psychology; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010349:Patient Compliance; D010546:Perphenazine / Q000627:therapeutic use; D010890:Pirenzepine / Q000031:analogs & derivatives / Q000627:therapeutic use; D011788:Quality of Life; D018570:Risk Assessment; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D010546:Perphenazine; D003024:Clozapine; D000077152:Olanzapine